In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques.
Forty million people are estimated to be infected with HIV-1, and only a small fraction of those have access to life-prolonging antiretroviral treatment. As the epidemic grows there is an urgent need for effective therapeutic and prophylactic vaccines. Nonhuman primate models of immunodeficiency vir...
Main Authors: | Asquith, B, Mclean, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
by: Donahoe, S, et al.
Published: (2000) -
Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus–infected rhesus macaques on antiretroviral therapy
by: Benjamin D. Varco-Merth, et al.
Published: (2022-05-01) -
Dynamics and correlates of CD8 T-Cell counts in Africans with primary human immunodeficiency virus type 1 infection
by: Prentice, H, et al.
Published: (2016) -
Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8+ T-Cell Subsets
by: Ellen Veel, et al.
Published: (2018-03-01) -
Tuberculin Skin Test and CD4+/CD8+ T Cell Counts in Adults Infected with the Human Immunodeficiency Virus in Medellín, Colombia
by: JI Rodríguez, et al.
Published: (1997-03-01)